Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Smith, AJ
- Contributor
-
Wietgrefe, SW
Reilly, CS
Southern, PJ
Duan, L.
Perkey, KE
Shang, L.
Johnson, R.
Haase, AT
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-O19
- URN
-
urn:nbn:de:1111-2016080724632
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smith, AJ
- Wietgrefe, SW
- Reilly, CS
- Southern, PJ
- Duan, L.
- Perkey, KE
- Shang, L.
- Johnson, R.
- Haase, AT
- SpringerLink (Online service)
Other Objects (12)
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
Anti-retroviral innate immune responses in multiple lymphoid tissues elicited by protective live attenuated SIV vaccination
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques
Publisher Correction: Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
Anti-retroviral innate immune responses in multiple lymphoid tissues elicited by protective live attenuated SIV vaccination
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques
Publisher Correction: Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
Anti-retroviral innate immune responses in multiple lymphoid tissues elicited by protective live attenuated SIV vaccination
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques
Publisher Correction: Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization